Intended for healthcare professionals

Re: Correspondence with the European Medicines Agency

Tom Jefferson, Researcher
The Cochrane CollaborationRome

In the letter, Jefferson explains that the points the Cochrane Collaboration would like to discuss are the effects of Tamiflu both in the treatment and post exposure prophylaxis (PEP) of influenza as well as the drug’s mode of action.